Active, Not Recruiting
Pembrolizumab and Blinatumomab in Treating Participants With Recurrent or Refractory Acute Lymphoblastic Leukemia
NCT03512405
- Conditions
- CD19 Positive, Hematologic Diseases, Hemic and Lymphatic Diseases, +12 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States